Clinical Research

We thrive on the cutting edge. Staying up to date on new eye treatments allows us to provide the best care options for you.


Our physicians carefully select clinical trials that offer patients new and exciting treatment opportunities.


Our research coordinators are here to answer any questions you may have about participation in clinical trials. Simply call our office and ask to speak to a research coordinator!

Here are our current studies:

Condition: Nonproliferative Diabetic Retinopathy


Study Name: Protocol W

Study Title: Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk

Condition: Diabetic Macular Edema

Sponsor: Novartis


Study Title: A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of brolucizumab every 4 weeks versus Aflibercept every 4 weeks in Adult Patients with Visual Impairment due to Diabetic Macular Edema

Condition: Wet Age-Related Macular Degeneration and Diabetic Macular Edema

Sponsor: Aerie Pharmaceuticals, Inc.

Study Name: Aerie

Study Title: First-in-Human Study of the Safety of AR-13503 Sustained Release Intravitreal Implant in Subjects with Neovascular Age-Related Macular Degeneration (nAMD) and Subjects with Diabetic Macular Edema (DME)

Condition: Neovascular Age-Related Macular Degeneration

Sponsor: Novartis

Study Name: MERLIN

Study Title: A multicenter, randomized, double-masked Phase 3a study to assess safety and efficacy of brolucizumab 6 mg q4 weeks compared to aflibercept 2 mg q4 weeks in patients with neovascular age-related macular degeneration (nAMD) with persistent retinal fluid

Condition: Neovascular Age-Related Macular Degeneration

Sponsor: Chengdu Kanghong Biotechnology

Study Name: PANDA

Study Title: A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration

Condition: Dry Age-Related Macular Degeneration

Sponsor: Apellis

Study Name: OAKS

Study Title: A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Same Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Condition: Vitreomacular Traction


Study Name: Protocol AG

Study Title: Randomized Clinical Trial Assessing the Effects of Pneumatic Vitreolysis on Vitreomacular Traction

Condition: Macular Hole


Study Name: Protocol AH

Study Title: Single-Arm Study Assessing the Effects of Pneumatic Vitreolysis on Macular Hole